CalciMedica reported revenue of -$0.27M and net income of -$7.70M for the quarter ended Jun 2026, down 160.6% year over year. This income statement covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||
| Revenue | 0.31M | 0.28M | 0.22M | 0.21M | -0.24M | -0.10M | -0.19M | -0.17M | -0.21M | -0.27M | ||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 4.02M | 4.27M | 2.92M | 2.26M | 1.24M | 1.92M | 6.49M | 3.81M | 2.77M | 2.78M | 2.94M | 4.16M | 3.55M | 3.83M | 4.22M | 4.05M | 3.85M | 3.11M | 3.48M | 2.10M | ||||||||
| Selling, General & AdministrativeSG&A | 4.00M | 4.43M | 1.29M | 1.33M | 2.04M | 1.18M | 15.85M | 2.77M | 2.06M | 1.54M | 2.82M | 2.37M | 2.19M | 2.34M | 2.27M | 2.57M | 1.77M | 1.28M | 2.13M | 1.91M | ||||||||
| Restructuring CostsRestructuring | 2.44M | 0.53M | ||||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | -2.44M | -0.53M | ||||||||||||||||||||||||||
| Operating ExpensesOpex | 8.02M | 8.70M | 4.21M | 3.59M | 3.29M | 3.10M | 22.34M | 6.58M | 4.83M | 4.32M | 5.77M | 6.53M | 5.74M | 6.17M | 6.50M | 6.62M | 5.62M | 4.38M | 5.61M | 4.01M | ||||||||
| Operating IncomeOp. Inc | -8.02M | -8.70M | -4.21M | -3.59M | -3.29M | -3.10M | -22.34M | -6.58M | -4.83M | -4.32M | -5.77M | -6.53M | -5.74M | -6.17M | -6.50M | -6.62M | -5.62M | -4.38M | -5.61M | -4.01M | ||||||||
| EBIT | -8.02M | -8.70M | -4.21M | -3.59M | -3.29M | -3.10M | -22.34M | -6.58M | -4.83M | -4.32M | -5.77M | -6.53M | -5.74M | -6.17M | -6.50M | -6.62M | -5.62M | -4.38M | -5.61M | -4.01M | ||||||||
| Non-operating items | ||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.45M | 0.32M | 0.33M | 0.33M | 0.32M | 0.33M | ||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.03M | 0.03M | 0.04M | 0.06M | 0.17M | 0.31M | ||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.58M | 0.59M | 0.76M | 1.86M | 3.17M | 0.28M | 0.21M | 5.59M | 2.30M | -0.10M | 1.70M | 1.70M | 0.50M | -2.00M | -6.27M | 10.80M | -3.60M | |||||||||||
| Non Operating IncomeNon Op. Inc. | 0.58M | 0.56M | 0.71M | 4.52M | 3.05M | 0.28M | 0.21M | 0.17M | 5.90M | 2.58M | 0.12M | 1.91M | 1.46M | 0.67M | -2.19M | -6.38M | 10.59M | -3.64M | ||||||||||
| Net income details | ||||||||||||||||||||||||||||
| EBT | -7.99M | -8.68M | -4.18M | -3.53M | -3.12M | -2.80M | -22.34M | -6.58M | -4.83M | -4.32M | -5.77M | -6.53M | -5.74M | -6.17M | -6.94M | -6.95M | -5.94M | -4.71M | -5.93M | -4.34M | ||||||||
| Profit After TaxPAT | -7.99M | -8.69M | -3.63M | -3.03M | -2.58M | 0.10M | -19.29M | -6.30M | -4.62M | -4.15M | 0.13M | -3.95M | -5.62M | -4.26M | -5.04M | -5.96M | -7.80M | -10.80M | 4.98M | -7.70M | ||||||||
| Income from Continuing OperationsIncome (Continuing) | -7.99M | -8.68M | -4.18M | -3.53M | -3.12M | -2.80M | -22.34M | -6.58M | -4.83M | -4.32M | -5.77M | -6.53M | -5.74M | -6.17M | -6.94M | -6.95M | -5.94M | -4.71M | -5.93M | -4.34M | ||||||||
| Consolidated Net IncomeConsol Net Inc. | -7.99M | -8.68M | -4.18M | -3.53M | -3.12M | -2.80M | -22.34M | -6.58M | -4.83M | -4.32M | -5.77M | -6.53M | -5.74M | -6.17M | -6.94M | -6.95M | -5.94M | -4.71M | -5.93M | -4.34M | ||||||||
| Income towards Parent CompanyParent Net Inc | -7.99M | -8.68M | -4.18M | -3.53M | -3.12M | -2.80M | -22.34M | -6.58M | -4.83M | -4.32M | -5.77M | -6.53M | -5.74M | -6.17M | -6.94M | -6.95M | -5.94M | -4.71M | -5.93M | -4.34M | ||||||||
| Preferred Dividend PaymentsPref Dividends | ||||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -7.99M | -8.68M | -4.18M | -3.53M | -3.12M | -2.80M | -19.29M | -6.30M | -4.62M | -4.15M | 0.13M | -3.95M | -5.62M | -4.26M | -6.94M | -6.95M | -5.94M | -4.71M | -5.93M | -4.34M | ||||||||
| Additional items | ||||||||||||||||||||||||||||
| EPS (Basic) | -26.27 | -28.64 | -13.69 | -11.53 | -10.13 | -9.11 | -117.17 | -5.57 | -4.08 | -4.62 | 0.07 | -1.78 | -2.52 | -1.89 | -2.46 | -2.32 | -1.97 | -1.57 | -1.87 | -1.27 | ||||||||
| EPS (Diluted) | -26.27 | -28.64 | -265.38 | -11.53 | -10.13 | -9.11 | -117.17 | -5.57 | -4.08 | -4.62 | 0.06 | -1.78 | -2.52 | -1.89 | -2.46 | -2.32 | -1.97 | -1.57 | -1.82 | -1.27 | ||||||||
| Shares Outstanding | 0.30M | 0.30M | 0.31M | 0.31M | 0.31M | 0.31M | 0.16M | 1.13M | 1.13M | 0.90M | 1.95M | 2.23M | 2.23M | 2.25M | 2.82M | 3.00M | 3.02M | 3.00M | 3.16M | 3.42M | ||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.30M | 0.30M | 0.02M | 0.31M | 0.31M | 0.31M | 0.16M | 1.13M | 1.13M | 0.90M | 2.01M | 2.23M | 2.23M | 2.25M | 2.82M | 3.00M | 3.02M | 3.00M | 3.27M | 3.42M | ||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.30M | 0.31M | 0.31M | 0.31M | 0.31M | 0.31M | 0.16M | 1.13M | 1.14M | 0.90M | 2.15M | 2.15M | 2.15M | 2.70M | 2.79M | 2.79M | 2.85M | 3.09M | 3.15M | 3.42M | ||||||||
| EBITDA | -8.02M | -8.70M | -4.21M | -3.59M | -3.29M | -3.10M | -22.34M | -6.58M | -4.83M | -4.32M | -5.77M | -6.53M | -5.74M | -6.17M | -6.50M | -6.62M | -5.62M | -4.38M | -5.61M | -4.01M | ||||||||
| Interest ExpensesInt Expense | 0.45M | 0.32M | 0.33M | 0.33M | 0.32M | 0.33M |